Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder

Status unconfirmed · Not applicable

Conditions studied: Opioid Use, Pain, Postoperative, Opioid Use, Unspecified, Trauma, Opioid-use Disorder

In brief

The investigators will enroll 100 participants using a randomized control trial design to implement and evaluate an individualized opioid taper program supporting rural Primary Care Physicians (PCPs) caring for patients with moderate to severe trauma discharged on opioids. This study will link a trauma center Physician Assistant (PA) with rural PCPs to facilitate pain care and the individualized opioid taper. The investigators seek to improve patient's pain and opioid outcomes and support the PCPs who assume care for these complex patients after hospital discharge. Our long term goal is to provide a service that will help trauma patients as they go back into primary care and into pain- and opioid-free living.

Key facts

Study ID

NCT04275258

Run by

University of Washington

People needed

100

Starts

2020-06-01

Expected to finish

2022-01-31

Last updated by the study team

2021-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be at least 18 years old
• Injury Severity Score of 9 or greater
• Resident of Washington state
• Will be discharged to a rural zip code outside of king county.
• Glasgow Coma Score of 15
• Able to read, speak, and write English or Spanish.
• Has an identifiable PCP or willing to accept referral to a local Federally Qualified Health Center (FQHC)
• Has an insurer included in the All Payer Claims Database
• Planned to be discharged on opioid medication
• Planned to be discharged back to the community

You may not qualify if…

• Less than 18 years old
• Injury Severity Score less than 9
• Patient is in judicial custody
• Resident of a state other than Washington
• Will not be discharged to a rural zip code outside of king county.
• Evidence of OUD diagnosis (including using heroin or other illicit opioids in the past month, a DSM-5 OUD diagnosis, or evidence of taking methadone, buprenorphine, or naltrexone).
• Currently in cancer treatment or enrolled in palliative or hospice care
• Residing in a nursing home or assisted living facility
• Using any implanted device for pain control
• Self-report of heroin or other illicit opioid use in the past month
• Psychotic symptoms, psychiatric hospitalization or suicide attempts in the past year (including current admission).

Where it is running

• Harborview Medical Center — Seattle, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.